146 related articles for article (PubMed ID: 37726872)
21. Systematic Review and Meta-Analysis of the Influence of Genetic Variation on Ototoxicity in Platinum-Based Chemotherapy.
Hong DZ; Ong TCC; Timbadia DP; Tan HTA; Kwa ED; Chong WQ; Goh BC; Loh WS; Loh KS; Tan EC; Tay JK
Otolaryngol Head Neck Surg; 2023 Jun; 168(6):1324-1337. PubMed ID: 36802061
[TBL] [Abstract][Full Text] [Related]
22. Ototoxicity and long-term hearing outcome in pediatric patients receiving cisplatin.
Sriyapai T; Thongyai K; Phuakpet K; Vathana N; Buaboonnam J; Sanpakit K
Turk J Pediatr; 2022; 64(3):531-541. PubMed ID: 35899566
[TBL] [Abstract][Full Text] [Related]
23. Promoter region variation in NFE2L2 influences susceptibility to ototoxicity in patients exposed to high cumulative doses of cisplatin.
Spracklen TF; Vorster AA; Ramma L; Dalvie S; Ramesar RS
Pharmacogenomics J; 2017 Dec; 17(6):515-520. PubMed ID: 27457817
[TBL] [Abstract][Full Text] [Related]
24. Common variants in ACYP2 influence susceptibility to cisplatin-induced hearing loss.
Xu H; Robinson GW; Huang J; Lim JY; Zhang H; Bass JK; Broniscer A; Chintagumpala M; Bartels U; Gururangan S; Hassall T; Fisher M; Cohn R; Yamashita T; Teitz T; Zuo J; Onar-Thomas A; Gajjar A; Stewart CF; Yang JJ
Nat Genet; 2015 Mar; 47(3):263-6. PubMed ID: 25665007
[TBL] [Abstract][Full Text] [Related]
25. Different infusion durations for preventing platinum-induced hearing loss in children with cancer.
van As JW; van den Berg H; van Dalen EC
Cochrane Database Syst Rev; 2018 Jul; 7(7):CD010885. PubMed ID: 29975402
[TBL] [Abstract][Full Text] [Related]
26. Different infusion durations for preventing platinum-induced hearing loss in children with cancer.
van As JW; van den Berg H; van Dalen EC
Cochrane Database Syst Rev; 2016 Aug; (8):CD010885. PubMed ID: 27498707
[TBL] [Abstract][Full Text] [Related]
27. Genetic variants associated with cisplatin-induced ototoxicity.
Oldenburg J; Fosså SD; Ikdahl T
Pharmacogenomics; 2008 Oct; 9(10):1521-30. PubMed ID: 18855538
[TBL] [Abstract][Full Text] [Related]
28. Cisplatin ototoxicity in children: risk factors and its relationship with polymorphisms of DNA repair genes ERCC1, ERCC2, and XRCC1.
Turan C; Kantar M; Aktan Ç; Kosova B; Orman M; Bilgen C; Kirazlı T
Cancer Chemother Pharmacol; 2019 Dec; 84(6):1333-1338. PubMed ID: 31586226
[TBL] [Abstract][Full Text] [Related]
29. Analysis of genetic and non genetic risk factors for cisplatin ototoxicity in pediatric patients.
Olgun Y; Aktaş S; Altun Z; Kırkım G; Kızmazoğlu DÇ; Erçetin AP; Demir B; İnce D; Mutafoğlu K; Demirağ B; Ellidokuz H; Olgun N; Güneri EA
Int J Pediatr Otorhinolaryngol; 2016 Nov; 90():64-69. PubMed ID: 27729156
[TBL] [Abstract][Full Text] [Related]
30. Genetic Variants as Predictive Markers for Ototoxicity and Nephrotoxicity in Patients with Locally Advanced Head and Neck Cancer Treated with Cisplatin-Containing Chemoradiotherapy (The PRONE Study).
Driessen CM; Ham JC; Te Loo M; van Meerten E; van Lamoen M; Hakobjan MH; Takes RP; van der Graaf WT; Kaanders JH; Coenen MJH; van Herpen CM
Cancers (Basel); 2019 Apr; 11(4):. PubMed ID: 30999660
[TBL] [Abstract][Full Text] [Related]
31. Ototoxicity Review: A Growing Number of Non-Platinum-Based Chemo- and Immunotherapies.
Naples JG; Rice-Narusch W; Watson NW; Ghulam-Smith M; Holmes S; Li D; Jalisi S
Otolaryngol Head Neck Surg; 2023 Apr; 168(4):658-668. PubMed ID: 35439087
[TBL] [Abstract][Full Text] [Related]
32. Different infusion durations for preventing platinum-induced hearing loss in children with cancer.
van As JW; van den Berg H; van Dalen EC
Cochrane Database Syst Rev; 2020 Jan; 1(1):CD010885. PubMed ID: 31961948
[TBL] [Abstract][Full Text] [Related]
33. SOD2 genetic variant associated with treatment-related ototoxicity in cisplatin-treated pediatric medulloblastoma.
Brown AL; Lupo PJ; Okcu MF; Lau CC; Rednam S; Scheurer ME
Cancer Med; 2015 Nov; 4(11):1679-86. PubMed ID: 26400460
[TBL] [Abstract][Full Text] [Related]
34. [The analysis of the association of the polymorphic variants of the TPMT, COMT, and ABCC3 genes with the development of hearing disorders induced by the cisplatin treatment].
Mironovich OL; Bliznetz EA; Garbaruk ES; Belogurova MB; Subora NV; Varfolomeeva SR; Kachanov DY; Shamanskaya TV; Markova TG; Polyakov AV
Vestn Otorinolaringol; 2018; 83(4):60-66. PubMed ID: 30113582
[TBL] [Abstract][Full Text] [Related]
35. The role of inherited TPMT and COMT genetic variation in cisplatin-induced ototoxicity in children with cancer.
Yang JJ; Lim JY; Huang J; Bass J; Wu J; Wang C; Fang J; Stewart E; Harstead EH; E S; Robinson GW; Evans WE; Pappo A; Zuo J; Relling MV; Onar-Thomas A; Gajjar A; Stewart CF
Clin Pharmacol Ther; 2013 Aug; 94(2):252-9. PubMed ID: 23820299
[TBL] [Abstract][Full Text] [Related]
36. Cisplatin-Induced Ototoxicity: A Concise Review of the Burden, Prevention, and Interception Strategies.
Chattaraj A; Syed MP; Low CA; Owonikoko TK
JCO Oncol Pract; 2023 May; 19(5):278-283. PubMed ID: 36921239
[TBL] [Abstract][Full Text] [Related]
37. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
[TBL] [Abstract][Full Text] [Related]
38. Pharmacogenetics of chemotherapy treatment response and -toxicities in patients with osteosarcoma: a systematic review.
Hurkmans EGE; Brand ACAM; Verdonschot JAJ; Te Loo DMWM; Coenen MJH
BMC Cancer; 2022 Dec; 22(1):1326. PubMed ID: 36536332
[TBL] [Abstract][Full Text] [Related]
39. Concordance between the chang and the International Society of Pediatric Oncology (SIOP) ototoxicity grading scales in patients treated with cisplatin for medulloblastoma.
Bass JK; Huang J; Onar-Thomas A; Chang KW; Bhagat SP; Chintagumpala M; Bartels U; Gururangan S; Hassall T; Heath JA; McCowage G; Cohn RJ; Fisher MJ; Robinson G; Broniscer A; Gajjar A; Gurney JG
Pediatr Blood Cancer; 2014 Apr; 61(4):601-5. PubMed ID: 24504791
[TBL] [Abstract][Full Text] [Related]
40. [Research progress on the relationship between cisplatin ototoxicity and autophagy].
Liang Z; Cheng G; Zhang T; Jia H
Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2020 Feb; 34(2):189-192. PubMed ID: 32086932
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
